Hostname: page-component-78c5997874-g7gxr Total loading time: 0 Render date: 2024-11-05T04:14:55.519Z Has data issue: false hasContentIssue false

Flavonoids as anti-inflammatory agents

Published online by Cambridge University Press:  23 June 2010

Mauro Serafini*
Affiliation:
Antioxidant Research Laboratory, INRAN, Via Ardeatina 546, 00178Rome, Italy
Ilaria Peluso
Affiliation:
Antioxidant Research Laboratory, INRAN, Via Ardeatina 546, 00178Rome, Italy
Anna Raguzzini
Affiliation:
Antioxidant Research Laboratory, INRAN, Via Ardeatina 546, 00178Rome, Italy
*
*Corresponding author: Mauro Serafini, fax +39 0651494550, email [email protected]
Rights & Permissions [Opens in a new window]

Abstract

Epidemiological evidence suggests that a high intake of plant foods is associated with lower risk of chronic diseases. However, the mechanism of action and the components involved in this effect have not been identified clearly. In recent years, the scientific community has agreed to focus its attention on a class of secondary metabolites extensively present in a wide range of plant foods: the flavonoids, suggested as having different biological roles. The anti-inflammatory actions of flavonoids in vitro or in cellular models involve the inhibition of the synthesis and activities of different pro-inflammatory mediators such as eicosanoids, cytokines, adhesion molecules and C-reactive protein. Molecular activities of flavonoids include inhibition of transcription factors such as NF-κB and activating protein-1 (AP-1), as well as activation of nuclear factor-erythroid 2-related factor 2 (Nrf2). However, the in vitro evidence might be somehow of limited impact due to the non-physiological concentrations utilized and to the fact that in vivo flavonoids are extensively metabolized to molecules with different chemical structures and activities compared with the ones originally present in the food. Human studies investigating the effect of flavonoids on markers of inflammation are insufficient, and are mainly focused on flavonoid-rich foods but not on pure molecules. Most of the studies lack assessment of flavonoid absorption or fail to associate an effect on inflammation with a change in circulating levels of flavonoids. Human trials with appropriate placebo and pure flavonoid molecules are needed to clarify if flavonoids represent ancillary ingredients or key molecules involved in the anti-inflammatory properties of plant foods.

Type
3rd International Immunonutrition Workshop
Copyright
Copyright © The Authors 2010

Abbreviation:
AP-1

activating protein-1

CRP

C-reactive protein

LPS

lipopolysaccharide

MAPK

mitogen-activated protein kinase

It is widely recognized that lifestyle factors, particularly diet, play a paramount role in the development or prevention of degenerative diseases(Reference Hamer and Steptoe1, Reference Serafini, Villano and Spera2). Thus, there is growing interest worldwide in the prospect that overall diet as well as particular foods can promote and help maintain a good health status. Evidence has been provided that suggests that dietary patterns rich in foods of plant origin, such as fruits and vegetables, play a key role in disease prevention through a multi-factorial action involving a modulation of the immune system and the inflammatory response(Reference Raskin, Ribnicky and Komamytsky3, Reference Rates4). If the inflammatory response is not properly controlled, excess inflammatory stress may be induced, becoming a key modulator of endothelial damage playing a role in the pathogenesis of risk factors for CVD including obesity, hyperglycaemia and dyslipidaemia(Reference Hamer and Steptoe1). Inflammatory response mediated by acute-phase proteins such as C-reactive protein (CRP) and cytokines such as IL-6 may directly influence plaque vulnerability and rupture(Reference Blake and Ridker5). TNFα promotes the inflammatory cascade within the arterial wall, by inducing endothelial cell injury, as well as regulating leucocyte activation, maturation, cytokine and chemokine release, and production of reactive oxygen and nitrogen intermediates(Reference McKellar, McCarey and Sattar6). Soluble forms of cellular adhesion molecules, such as intercellular adhesion molecule-1 and vascular cell adhesion molecule-1, are considered to be markers of endothelial activation(Reference Frijns, Kappelle and van Gijn7) elevated in patients suffering from CVD(Reference Zeitler, Ko and Zimmermann8).

Polyphenols are secondary metabolites of plants involved in pigmentation, reproduction and protection against pathogens(Reference Manach, Scalbert and Morand9). Currently, there are more than 8000 known polyphenols sharing a common chemical structure (hydroxyl group on aromatic ring) with different constituents. Flavonoids are the most abundant polyphenols present in the human diet and represent a class of molecules characterized by a C6–C3–C6 backbone structure(Reference Manach, Scalbert and Morand9). Flavonoids can be divided into several subclasses according to different constituents such as flavanones, flavone, flavanols and flavonols. They can be found in almost all foods of vegetable origin and are present in high amounts in apples, onions, red wine, grapes, citrus fruits, tea, berries and olive oil. Among the different flavonols, myricetin, kaempferol and quercetin are the most representative. Catechins are the most abundant flavanols and are mainly contained in tea leaves. Flavanones are mainly represented by taxifolin, naringinin and hesperitin. The main sources of flavanones are citrus fruits. Flavones, luteolin, wogonin and apigenin are less common and identified in sweet red pepper and celery. In addition to these flavonoids, other subclasses are present such as proanthocyanidins and their oligomers present in cocoa products.

A growing number of observational epidemiological studies have examined the association between the intake of foods rich in polyphenols (onions, apples, tea, cocoa and red wine) as well as of individual dietary flavonoids (mainly flavonols, flavones and catechins) and chronic diseases(Reference Arts and Hollman10). Overall, the epidemiological evidence generally shows that a higher flavonoid intake is associated with lower CVD(Reference Zern and Fernandez11) and cancer risk(Reference Butt and Sultan12, Reference Ramos13). However, intervention trials in human subjects using pure compounds are scarce and studies with flavonoid-rich foods provided contrasting findings, failing to identify the flavonoids as the molecules responsible for the observed effect(Reference Taubert, Roesen and Lehmann14Reference Serafini, Testa and Villaño16). However, it must be considered that the biological activities of flavonoid-rich foods are critically determined by their bioavailability. The most abundant flavonoids in the diet are not always those able to reach the highest levels in human circulation. We showed(Reference Serafini, Bugianesi and Salucci17) that, in healthy subjects, plasma concentrations of caffeic acid (34 μg/l basal, 63 μg/l at 3 h), p-coumaric acid (46 μg/l basal, 85 μg/l at 3 h) and quercetin (46 μg/l basal, 66 μg/l at 3 h) after ingestion of 250 g lettuce do not reflect their content in food (31·7 mg caffeic acid, 7·3 mg p-coumaric acid and 12·7 mg quercetin). Flavonoids can be absorbed in the stomach and at small intestine level by passive diffusion or active transport(Reference Passamonti, Vrbovsek and Vazo18, Reference Manach and Donovan19). Once absorbed, metabolism of flavonoids in humans involves a biotransformation through enzymic conjugation with sulphate, methyl or glucuronide groups both in the small intestine epithelial cells and liver(Reference Manach and Donovan19). Variable amounts of flavonoids, not absorbed in the upper gastrointestinal tract, reach the colon where they are subject to the action of the colon microflora, resulting in cleavage of glycosidic linkages and the breakdown of the flavonoid heterocycle into phenolic acids and aldehydes(Reference Aura, Martin-Lopez and O'Leary20Reference Vitaglione, Donnarumma and Napolitano24). These microbial catabolites are absorbed into the circulatory system from the large intestine(Reference Manach, Williamson and Morand25). Upon absorption, polyphenols are readily metabolized in intestinal cells to form glucuronide and sulphate conjugates that appear in the portal blood.

The present paper will review the more recent evidence regarding the role of flavonoids as dietary modulators of the cascade of events associated with inflammatory responses.

Anti-inflammatory properties of flavonoids: evidence from in vitro and cellular models

The molecular mechanisms involved in the anti-inflammatory activities of flavonoids have been suggested to include: inhibition of pro-inflammatory enzymes, such as cyclooxygenase-2, lipoxygenase and inducible NO synthase, inhibition of NF-κB and activating protein-1 (AP-1) and activation of phase II antioxidant detoxifying enzymes, mitogen-activated protein kinase (MAPK), protein kinase C and nuclear factor-erythroid 2-related factor 2(Reference Santangelo, Varì and Scazzocchio26Reference Yoon and Baek28). Cyclooxygenase-2 is inhibited by quercetin and kaempferol in rat peritoneal macrophages(Reference Welton, Tobias, Fiedler-Nagy, Cody, Middleton and Harborne29). Catechin weakly inhibits cyclooxygenase-2 but at a very high concentration (100 μm) with respect to the serum concentrations found following the ingestion of flavonoid-rich foods(Reference Noreen, Serrano and Perera30). Flavonols such as kaemferol, quercetin, morin and myricetin were found to be better lipoxygenase inhibitors than flavones. Flavanones such as naringenin were ineffective. In lipopolysaccharide (LPS)/cytokine-treated macrophages or macrophage cell lines, quercetin, apigenin and luteolin were found to inhibit NO production(Reference Kim, Murakami and Nakamura31). Using LPS-treated RAW cell lines, it was found that catechins and flavanones were not active in reducing NO production below a concentration of 100 μM(Reference Liang, Huang and Tsai32). Further evidence(Reference Kim, Cheon and Kim33) showed that the inhibitory effect of apigenin, genistein and kaempferol on NO production is mediated by an effect on inducible NO synthase down-regulation.

Inflammatory cytokines produced and regulated at the transcriptional level can either enhance or inhibit the inflammatory process. It has been observed that several flavonoids are able to decrease the expression of different pro-inflammatory cytokines/chemokines, including TNFα, IL-1β, IL-6, IL-8 and monocyte-chemoattractant protein-1, in different cell types such as RAW macrophages, Jurkat T-cells and peripheral blood mononuclear cells(Reference Santangelo, Varì and Scazzocchio26). Quercetin and catechins coupled their inhibitory action on TNFα and IL-1β to an enhanced release of the anti-inflammatory cytokine IL-10(Reference Santangelo, Varì and Scazzocchio26). Molecular mechanisms involved in their cytokine-modulating activity, including polyphenol-mediated inhibition of transcription factors NF-κB and AP-1 and reduction of MAPK activity, have been suggested as relevant anti-inflammatory pathways(Reference Santangelo, Varì and Scazzocchio26, Reference Bode and Dong34). Genistein has been reported to inhibit IL-1β, IL-6 and TNFα production in LPS-induced human blood monocytes(Reference Geng, Zhang and Lotz35). Genistein and silybin were shown to inhibit TNFα production from LPS-treated RAW cells(Reference Cho, Kim and Park36). Quercetin has been shown to affect inducible NO synthase and TNFα expression from LPS-induced RAW cells by inhibiting MAPK and AP-1 DNA binding(Reference Wadsworth, McDonald and Koop37, Reference Wadsworth and Koop38). Quercetin was shown to also affect NF-κB activation by extracellular signal-regulated kinase and p38 kinase inhibition(Reference Cho, Park and Kwon39). The effect on NF-κB was shown also for genistein, apigenin, kaempferol and epigallocatechin 3-gallate in LPS-stimulated macrophages. Evidence suggests that flavonoids are able to inhibit the expression of inflammation-related enzymes/proteins, partly by suppressing the activation of NF-κB, AP-1 and MAPK(Reference Santangelo, Varì and Scazzocchio26). Specifically, quercetin showed an inhibitory effect on extracellular signal-regulated kinase and c-Jun N-terminal kinase, while catechin inhibited p38 and c-Jun N-terminal kinase(Reference Santangelo, Varì and Scazzocchio26). The AP-1 transcription factors and AP-1 factor-associated signal transduction, implicated in inflammatory response, are important targets of flavonoid action(Reference Bode and Dong34, Reference Balasubramanian, Efimova and Eckert40). In addition, induction of nuclear factor-erythroid 2-related factor, the transcription factor responsible for both constitutive and inducible expressions of the antioxidant responsive element-regulated genes(Reference Gopalakrishnan and Tony Kong41), suppressed MCP-1 and vascular cell adhesion molecule-1 expression, monocyte adhesion to endothelial cells and transmigration, activation of p38 MAPK and inhibited atherosclerotic lesion formation in mice and rabbit(Reference Chen, Dodd and Thomas42). The body of evidence suggests that dietary flavonoids can modulate inflammatory responses also through an activation of pathways inducing antioxidant transcription and detoxification defence systems, such as glutathione peroxidase, haem oxygenases, γ-glutamylcysteine synthetase, superoxide dismutase and glutathione reductase, through anti-oxidant responsive element(Reference Masella, Di Benedetto and Varì43Reference Mann, Rowlands and Li46).

Anti-inflammatory properties of flavonoids: human studies

Dietary intervention trials investigating the effect of flavonoids on markers of inflammation in human subjects are scarce and are focused on a limited number of foods of plant origin such as black and green teas, fruit juices, grape extract and red wine, as described and summarized in Table 1. Four-week administration of black tea, green tea and green tea extracts had no effect on the inflammatory markers IL-6, IL-1β, TNFα, CRP and fibrinogen(Reference de Maat, Pijl and Kluft47). However, the same period of time was enough to show a reduction of P-selectin levels concomitantly with an increase of urinary 4-O-methyl gallic acid, following black tea supplementation(Reference Hodgson, Puddey and Mori48). In agreement with this evidence, Murphy et al.(Reference Murphy, Chronopoulos and Singh15) showed an effect on P-selectin plasma levels together with an increase of plasma catechins after 4 weeks of cocoa tablet administration(Reference Murphy, Chronopoulos and Singh15). Widlansky et al.(Reference Widlansky, Duffy and Hamburg49) observed, in patients with coronary artery disease, an increase in plasma catechins concentration after 4 weeks of daily ingestion of 900 ml black tea without any effect on CRP. In diabetic subjects, CRP and IL-6, were unaffected by green tea (900 ml) administration(Reference Ryu, Lee and Lee50) as were fibrinogen, TNFα, intercellular adhesion molecule and vascular cell adhesion molecule after 6 months of daily consumption of black tea in diabetic subjects(Reference Mukamal, MacDermott and Vinson51). Steptoe et al.(Reference Steptoe, Gibson and Vuononvirta52) showed a reduction in CRP levels after 6 weeks of black tea consumption; however, no evidence was provided regarding the extent of flavonoid absorption.

Table 1. Overview of human intervention studies on the anti-inflammatory effects of plant foods and flavonoids

PP, polyphenol; n, number of total subjects; ↓, decrease; ↑, increase; BT, black tea; GT, green tea; GTE, green tea extract; RGJ, red grape juice; RW, red wine; DRW, de-alcoholized red wine; GE, grape extract; PRJ, polyphenol-rich juices; ICAM-1, intercellular adhesion molecule-1; VCAM-1, vascular cell adhesion molecule-1; CRP, C-reactive protein; NK, natural killer; TGF-β, transforming growth factor-β; IFN-γ, interferon-γ; COX-2, cyclooxygenase 2; ECG, epicatechin gallate; EGCG, epigallocatechin gallate; EGC, epigallocatechin; EC, epicatechin.

Studies with alternative sources of dietary flavonoids such as grape juice and red wine were also contradictory. Watzl et al. showed that both acute(Reference Watzl, Bub and Briviba53) and chronic(Reference Watzl, Bub and Pretzer54) administration of red wine, de-alcoholized red wine and red grape juice had no effect on cytokine production, phagocytic activity of neutrophils and monocytes, lymphocyte proliferation and lytic activity of natural killer cells. However, Estruch et al.(Reference Estruch, Sacanella and Badia55) found reduced plasma levels of fibrinogen, IL-1α, CRP, vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 and an increase in plasma levels of epigallocatechin, after 4 weeks of red wine consumption. Chronic supplementation with red grape juice and grape extract reduced neutrophil NADPH oxidase activity(Reference Castilla, Dávalos and Teruel56) and TNFα in postmenopausal women(Reference Zern, Wood and Greene57). Polyphenol-rich juices enhanced immune function as showed by increases in lymphocyte proliferation, IL-2 secretion and lytic activity of natural killer cells(Reference Bub, Watzl and Blockhaus58). In all these studies, neither plasma nor urinary flavonoid levels were measured.

Long-term intervention studies conducted using soya as a source of bioactive molecules showed reduction in levels of vascular cell adhesion molecule-1 and CRP(Reference Fanti, Asmis and Stephenson59, Reference Nasca, Zhou and Welty60), but also a lack of effect on CRP(Reference Jenkins, Kendall and Connelly61Reference Ryan-Borchers, Park and Chew63), TNFα(Reference Jenkins, Kendall and Connelly61, Reference Ryan-Borchers, Park and Chew63) and IL-6(Reference Nasca, Zhou and Welty60, Reference Maskarinec, Oum and Chaptman62). Increases in total isoflavones, genistein and daidzein(Reference Fanti, Asmis and Stephenson59) and genistein levels(Reference Ryan-Borchers, Park and Chew63) induced by long-term soya consumption were not associated with CRP reductions(Reference Fanti, Asmis and Stephenson59, Reference Ryan-Borchers, Park and Chew63).

When pure molecules were utilized, CRP and IL-8 were lowered by quercetin supplementation in runners(Reference Nieman, Henson and Davis64) and bikers(Reference Nieman, Henson and Davis65), while quercetin plasma levels increased. Other cytokines, such as IL-6(Reference Nieman, Henson and Davis64Reference Bae, Jung and Lee66) and TNFα(Reference Nieman, Henson and Davis65, Reference Bae, Jung and Lee66), were unaffected by quercetin supplementation, also when consumed in combination with vitamin C(Reference Bae, Jung and Lee66).

Conclusions

Although existing evidence indicates that flavonoids potentially display a multitargeting anti-inflammatory action, a clear conclusion on their effects in human subjects cannot be drawn. The large body of evidence in vitro and on cellular models might be somehow biased by the non-physiological concentrations (in the range of 5–100 μM) utilized. Human intervention studies have shown that absorption of flavonoids in the gastrointestinal tract is typically between 1 and 5% of the ingested dose, with the overall result of reaching plasma concentrations not higher than 1 μM following ingestion of flavonoid-rich food(Reference Manach, Scalbert and Morand9). Moreover, in vivo, flavonoids are extensively metabolized and transformed in molecules with different chemical structures and activities compared with the ones originally present in the food. The large majority of in vitro and cellular experiments have not been performed with the metabolites present in body fluids, thereby increasing the chance of misinterpretation of the results.

The experimental evidence in human subjects suggests a direct role for plant foods in modulating the inflammatory response in vivo. However, the mechanism and the molecules responsible for this effect have not been identified. The assumption that flavonoids might be responsible for the anti-inflammatory effect of plant food is not fully justified on the basis of the current in vivo evidence. Studies investigating the effect of flavonoids on markers of inflammation have been mainly focused on flavonoid-rich foods and not on pure molecules. Moreover, most of the studies lack assessment of flavonoid absorption or failed to associate the anti-inflammatory effect following ingestion of plant foods with changes in circulating levels of flavonoids. Plant foods are rich in flavonoids as well as other components such as antioxidants, vitamins, fibre and nutrients that may be involved in their biological activity. Specifically, planned human trials with proper placebo and pure molecules are needed to clarify whether flavonoids represent ancillary ingredients or key molecules involved in the anti-inflammatory properties of plant foods.

Acknowledgements

The authors declare that there is no conflict of interest. This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

References

1.Hamer, M & Steptoe, A (2006) Influence of specific nutrients on progression of atherosclerosis, vascular function, haemostasis and inflammation in coronary heart disease patients: a systematic review. Br J Nutr 95, 849859.CrossRefGoogle ScholarPubMed
2.Serafini, M, Villano, D, Spera, G et al. (2006) Redox molecules and cancer prevention: the importance of understanding the role of the antioxidant network. Nutr Cancer 56, 232240.CrossRefGoogle ScholarPubMed
3.Raskin, I, Ribnicky, DM, Komamytsky, S et al. (2002) Plants and human health in the twentyfirst century. Trends Biotechnol 20, 522531.CrossRefGoogle Scholar
4.Rates, SMK (2001) Plants as source of drugs. Toxicon 39, 603613.CrossRefGoogle ScholarPubMed
5.Blake, GJ & Ridker, PM (2001) Novel clinical markers of vascular wall inflammation. Circ Res 89, 763771.CrossRefGoogle ScholarPubMed
6.McKellar, GE, McCarey, DW, Sattar, N et al. (2009) Role for TNF in atherosclerosis? Lessons from autoimmune disease. Nat Rev Cardiol 6, 410417.CrossRefGoogle ScholarPubMed
7.Frijns, CJ, Kappelle, LJ, van Gijn, J et al. (1997) Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. Stroke 28, 22142218.CrossRefGoogle ScholarPubMed
8.Zeitler, H, Ko, Y, Zimmermann, C et al. (1997) Elevated serum concentrations of soluble adhesion molecules in coronary artery disease and acute myocardial infarction. Eur J Med Res 2, 389394.Google ScholarPubMed
9.Manach, C, Scalbert, A, Morand, C et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727747.CrossRefGoogle ScholarPubMed
10.Arts, IC & Hollman, PC (2005) Polyphenols and disease risk in epidemiologic studies. Am J Clin Nutr 81, 317S325S.CrossRefGoogle ScholarPubMed
11.Zern, TL & Fernandez, ML (2005) Cardioprotective effects of dietary polyphenols. J Nutr 135, 22912294.CrossRefGoogle ScholarPubMed
12.Butt, MS & Sultan, MT (2009) Green tea: nature's defense against malignancies. Crit Rev Food Sci Nutr 49, 463473.CrossRefGoogle ScholarPubMed
13.Ramos, S (2008) Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Mol Nutr Food Res 52, 507526.CrossRefGoogle ScholarPubMed
14.Taubert, D, Roesen, R, Lehmann, C et al. (2007) Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 298, 4960.CrossRefGoogle ScholarPubMed
15.Murphy, KJ, Chronopoulos, AK, Singh, I et al. (2003) Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function. Am J Clin Nutr 77, 14661473.CrossRefGoogle ScholarPubMed
16.Serafini, M, Testa, MF, Villaño, D et al. (2009) Antioxidant activity of blueberry fruit is impaired by association with milk. Free Radic Biol Med 46, 769774.CrossRefGoogle ScholarPubMed
17.Serafini, M, Bugianesi, R, Salucci, M et al. (2002) Effect of acute ingestion of fresh and stored lettuce (Lactuca sativa) on plasma total antioxidant capacity and antioxidant levels in human subjects. Br J Nutr 88, 615623.CrossRefGoogle ScholarPubMed
18.Passamonti, S, Vrbovsek, U, Vazo, A et al. (2003) The stomach as a site for anthocyanins absorption from food. FEBS Lett 544, 210213.CrossRefGoogle ScholarPubMed
19.Manach, C & Donovan, JL (2004) Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Radic Res 38, 771785.CrossRefGoogle ScholarPubMed
20.Aura, AM, Martin-Lopez, P, O'Leary, KA et al. (2005) In vitro metabolism of anthocyanins by human gut microflora. Eur J Nutr 44, 133142.CrossRefGoogle ScholarPubMed
21.Keppler, K & Humpf, HU (2005) Metabolism of anthocyanins and theirphenolicdegradation products by the intestinal microflora. Bioorg Med Chem 13, 51955205.CrossRefGoogle ScholarPubMed
22.Meng, X, Sang, S, Zhu, N et al. (2002) Identification and characterization of methylated and ring-fissionmetabolites of tea catechins formed in humans, mice and rats. Chem Res Toxicol 15, 10421050.CrossRefGoogle ScholarPubMed
23.Rios, LY, Gonthier, MP, Remesy, C et al. (2003) Chocolate intake increases urinary excretion of polyphenol-derived phenolic acids in healthy human subjects. Am J Clin Nutr 77, 912918.CrossRefGoogle ScholarPubMed
24.Vitaglione, P, Donnarumma, G, Napolitano, A et al. (2007) Protocatechuic acid is the major human metabolite of cyanidinglucosides. J Nutr 137, 20432048.CrossRefGoogle ScholarPubMed
25.Manach, C, Williamson, G, Morand, C et al. (2005) Bioavailability and bioefficacy of polyphenols in humans I: review of 97 bioavailability studies. Am J Clin Nutr 81, 230S242S.CrossRefGoogle ScholarPubMed
26.Santangelo, C, Varì, R, Scazzocchio, B et al. (2007) Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita 43, 394405.Google ScholarPubMed
27.Middleton, E Jr, Kandaswami, C & Theoharides, TC (2000) The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 52, 673751.Google ScholarPubMed
28.Yoon, JH & Baek, SJ (2005) Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med J 46, 585596.CrossRefGoogle ScholarPubMed
29.Welton, AF, Tobias, LD, Fiedler-Nagy, C et al. (1986) Effect of flavonoids on arachidonic acid metabolism. In Plant flavonoids in biology and medicine, pp. 231242 [Cody, V, Middleton, E and Harborne, JB, editors]. New York: Alan R. Liss.Google Scholar
30.Noreen, Y, Serrano, G, Perera, P et al. (1998) Flavan-3-ols isolated from some medicinal plants inhibiting COX-1 and COX-2 catalysed prostaglandin biosynthesis. Planta Med 64, 520524.CrossRefGoogle ScholarPubMed
31.Kim, OK, Murakami, A, Nakamura, Y et al. (1998) Screening of edible Japanese plants for nitric oxide generation inhibitory activities in RAW 2647 cells. Cancer Lett 125, 199207.CrossRefGoogle Scholar
32.Liang, YC, Huang, YT, Tsai, SH et al. (1999) Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. Carcinogenesis 20, 19451952.CrossRefGoogle ScholarPubMed
33.Kim, HK, Cheon, BS, Kim, YH et al. (1999) Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 2647 and their structure–activity relationships. Biochem Pharmacol 58, 759765.CrossRefGoogle Scholar
34.Bode, AM & Dong, Z (2004) Targeting signal transduction pathways by chemopreventive agents. Mutat Res 555, 3351.CrossRefGoogle ScholarPubMed
35.Geng, Y, Zhang, B & Lotz, M (1993) Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol 151, 66926700.CrossRefGoogle ScholarPubMed
36.Cho, JY, Kim, PS, Park, J et al. (2000) Inhibitor of tumor necrosis factor-alpha production in lipopolysaccharide-stimulated RAW2647 cells from Amorpha fruticosa. J Ethnopharmacol 70, 127133.CrossRefGoogle Scholar
37.Wadsworth, TL, McDonald, TL & Koop, DR (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced signaling pathways involved in the release of tumor necrosis factor-alpha. Biochem Pharmacol 62, 963974.CrossRefGoogle ScholarPubMed
38.Wadsworth, TL & Koop, DR (2001) Effects of Ginkgo biloba extract (EGb 761) and quercetin on lipopolysaccharide-induced release of nitric oxide. Chem Biol Interact 137, 4358.CrossRefGoogle ScholarPubMed
39.Cho, SY, Park, SJ, Kwon, MJ et al. (2003) Quercetin suppresses proinflammatory cytokines production through MAP kinases and NF-kappaB pathway in lipopolysaccharide-stimulated macrophage. Mol Cell Biochem 243, 153160.CrossRefGoogle ScholarPubMed
40.Balasubramanian, S, Efimova, T & Eckert, RL (2002) Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes. J Biol Chem 277, 18281836.CrossRefGoogle ScholarPubMed
41.Gopalakrishnan, A & Tony Kong, AN (2008) Anticarcinogenesis by dietary phytochemicals: cytoprotection by Nrf2 in normal cells and cytotoxicity by modulation of transcription factors NF-kappa B and AP-1 in abnormal cancer cells. Food Chem Toxicol 46, 12571270.CrossRefGoogle ScholarPubMed
42.Chen, XL, Dodd, G, Thomas, S et al. (2006) Activation of Nrf2/ARE pathway protects endothelial cells from oxidant injury and inhibits inflammatory gene expression. Am J Physiol Heart Circ Physiol 290, H1862H1870.CrossRefGoogle ScholarPubMed
43.Masella, R, Di Benedetto, R, Varì, R et al. (2005) Novel mechanisms of natural antioxidant compounds in biological systems: involvement of glutathione and glutathione-related enzymes. J Nutr Biochem 16, 577586.CrossRefGoogle ScholarPubMed
44.Rahman, I, Biswas, SK & Kirkham, PA (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72, 14391452.CrossRefGoogle Scholar
45.Mann, GE, Niehueser-Saran, J, Watson, A et al. (2007) Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia. Sheng Li Xue Bao 59, 117127.Google ScholarPubMed
46.Mann, GE, Rowlands, DJ, Li, FY et al. (2007) Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res 75, 261274.CrossRefGoogle ScholarPubMed
47.de Maat, MP, Pijl, H, Kluft, C et al. (2000) Consumption of black and green tea had no effect on inflammation, haemostasis and endothelial markers in smoking healthy individuals. Eur J Clin Nutr 54, 757763.CrossRefGoogle ScholarPubMed
48.Hodgson, JM, Puddey, IB, Mori, TA et al. (2001) Effects of regular ingestion of black tea on haemostasis and cell adhesion molecules in humans. Eur J Clin Nutr 55, 881886.CrossRefGoogle ScholarPubMed
49.Widlansky, ME, Duffy, SJ, Hamburg, NM et al. (2005) Effects of black tea consumption on plasma catechins and markers of oxidative stress and inflammation in patients with coronary artery disease. Free Radic Biol Med 38, 499506.CrossRefGoogle ScholarPubMed
50.Ryu, OH, Lee, J, Lee, KW et al. (2006) Effects of green tea consumption on inflammation, insulin resistance and pulse wave velocity in type 2 diabetes patients. Diabetes Res Clin Pract 71, 356358.CrossRefGoogle ScholarPubMed
51.Mukamal, KJ, MacDermott, K, Vinson, JA et al. (2007) A 6-month randomized pilot study of black tea and cardiovascular risk factors. Am Heart J 154, 724.e1724.e6.CrossRefGoogle ScholarPubMed
52.Steptoe, A, Gibson, EL, Vuononvirta, R et al. (2007) The effects of chronic tea intake on platelet activation and inflammation: a double-blind placebo controlled trial. Atherosclerosis 193, 277282.CrossRefGoogle ScholarPubMed
53.Watzl, B, Bub, A, Briviba, K et al. (2002) Acute intake of moderate amounts of red wine or alcohol has no effect on the immune system of healthy men. Eur J Nutr 41, 264270.CrossRefGoogle ScholarPubMed
54.Watzl, B, Bub, A, Pretzer, G et al. (2004) Daily moderate amounts of red wine or alcohol have no effect on the immune system of healthy men. Eur J Clin Nutr 58, 4045.CrossRefGoogle ScholarPubMed
55.Estruch, R, Sacanella, E, Badia, E et al. (2004) Different effects of red wine and gin consumption on inflammatory biomarkers of atherosclerosis: a prospective randomized crossover trial. Effects of wine on inflammatory markers. Atherosclerosis 175, 117123.CrossRefGoogle ScholarPubMed
56.Castilla, P, Dávalos, A, Teruel, JL et al. (2008) Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients. Am J Clin Nutr 87, 10531061.CrossRefGoogle ScholarPubMed
57.Zern, TL, Wood, RJ, Greene, C et al. (2005) Grape polyphenols exert a cardioprotective effect in pre- and postmenopausal women by lowering plasma lipids and reducing oxidative stress. J Nutr 135, 19111917.CrossRefGoogle ScholarPubMed
58.Bub, A, Watzl, B, Blockhaus, M et al. (2003) Fruit juice consumption modulates antioxidative status, immune status and DNA damage. J Nutr Biochem 14, 9098.CrossRefGoogle ScholarPubMed
59.Fanti, P, Asmis, R, Stephenson, TJ et al. (2006) Positive effect of dietary soy in ESRD patients with systemic inflammation – correlation between blood levels of the soy isoflavones and the acute-phase reactants. Nephrol Dial Transplant 21, 22392246.CrossRefGoogle ScholarPubMed
60.Nasca, MM, Zhou, JR & Welty, FK (2008) Effect of soy nuts on adhesion molecules and markers of inflammation in hypertensive and normotensive postmenopausal women. Am J Cardiol 102, 8486.CrossRefGoogle Scholar
61.Jenkins, DJ, Kendall, CW, Connelly, PW et al. (2002) Effects of high- and low-isoflavone (phytoestrogen) soy foods on inflammatory biomarkers and proinflammatory cytokines in middle-aged men and women. Metabolism 51, 919924.CrossRefGoogle ScholarPubMed
62.Maskarinec, G, Oum, R, Chaptman, AK et al. (2009) Inflammatory markers in a randomised soya intervention among men. Br J Nutr 101, 17401744.CrossRefGoogle Scholar
63.Ryan-Borchers, TA, Park, JS, Chew, BP et al. (2006) Soy isoflavones modulate immune function in healthy postmenopausal women. Am J Clin Nutr 83, 11181125.CrossRefGoogle ScholarPubMed
64.Nieman, DC, Henson, DA, Davis, JM et al. (2007) Quercetin ingestion does not alter cytokine changes in athletes competing in the Western States Endurance Run. J Interferon Cytokine Res 27, 10031011.CrossRefGoogle Scholar
65.Nieman, DC, Henson, DA, Davis, JM et al. (2007) Quercetin's influence on exercise-induced changes in plasma cytokines and muscle and leukocyte cytokine mRNA. J Appl Physiol 103, 17281735.CrossRefGoogle ScholarPubMed
66.Bae, SC, Jung, WJ, Lee, EJ et al. (2009) Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients. J Am Coll Nutr 28, 5662.CrossRefGoogle ScholarPubMed
Figure 0

Table 1. Overview of human intervention studies on the anti-inflammatory effects of plant foods and flavonoids